Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.
Curbelo J, Luquero Bueno S, Galván-Román JM, Ortega-Gómez M, Rajas O, Fernández-Jiménez G, Vega-Piris L, Rodríguez-Salvanes F, Arnalich B, Díaz A, Costa R, de la Fuente H, Lancho Á, Suárez C, Ancochea J, Aspa J. Curbelo J, et al. Among authors: luquero bueno s. PLoS One. 2017 Mar 16;12(3):e0173947. doi: 10.1371/journal.pone.0173947. eCollection 2017. PLoS One. 2017. PMID: 28301543 Free PMC article.
The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers.
Rajas O, Ortega-Gómez M, Galván Román JM, Curbelo J, Fernández Jiménez G, Vega Piris L, Rodríguez Salvanes F, Arnalich B, Luquero Bueno S, Díaz López A, de la Fuente H, Suárez C, Ancochea J, Aspa J. Rajas O, et al. Among authors: luquero bueno s. BMC Pulm Med. 2014 Dec 12;14:197. doi: 10.1186/1471-2466-14-197. BMC Pulm Med. 2014. PMID: 25495677 Free PMC article.
Correction: Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.
Curbelo J, Luquero Bueno S, Galván-Román JM, Ortega-Gómez M, Rajas O, Fernández-Jiménez G, Vega-Piris L, Rodríguez-Salvanes F, Arnalich B, Díaz A, Costa R, de la Fuente H, Lancho Á, Suárez C, Ancochea J, Aspa J. Curbelo J, et al. Among authors: luquero bueno s. PLoS One. 2019 Feb 22;14(2):e0212915. doi: 10.1371/journal.pone.0212915. eCollection 2019. PLoS One. 2019. PMID: 30794692 Free PMC article.
Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired Pneumonia.
Curbelo J, Rajas O, Arnalich B, Galván-Román JM, Luquero-Bueno S, Ortega-Gómez M, Lancho A, Roy E, Sánchez Azofra A, Mateo Jiménez G, Gómez M, Moldenhauer F, Aspa J. Curbelo J, et al. Among authors: luquero bueno s. Arch Bronconeumol (Engl Ed). 2019 Sep;55(9):472-477. doi: 10.1016/j.arbres.2019.02.005. Epub 2019 Mar 23. Arch Bronconeumol (Engl Ed). 2019. PMID: 30914210 English, Spanish.
Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumonia.
Galván-Román JM, Lancho-Sánchez Á, Luquero-Bueno S, Vega-Piris L, Curbelo J, Manzaneque-Pradales M, Gómez M, de la Fuente H, Ortega-Gómez M, Aspa J. Galván-Román JM, et al. Among authors: luquero bueno s. PLoS One. 2020 Oct 23;15(10):e0240926. doi: 10.1371/journal.pone.0240926. eCollection 2020. PLoS One. 2020. PMID: 33095833 Free PMC article.
Benefits of the application of heat and pressure on peripheral venous cannulation in adults: A randomized controlled trial.
Simón-López LC, Luquero-Bueno S, Ovejero-Benito MC, Cuesta-Lozano D, Goodman-Casanova JM, Vargas-Castrillón E, Mazarro DO, De Miguel-Cáceres A, Posada-Moreno P, Zaragoza-García I, Ortuño-Soriano I. Simón-López LC, et al. Among authors: luquero bueno s. J Adv Nurs. 2021 Mar;77(3):1533-1545. doi: 10.1111/jan.14655. Epub 2020 Nov 20. J Adv Nurs. 2021. PMID: 33219590 Clinical Trial.
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide.
Soria-Chacartegui P, Zubiaur P, Ochoa D, Navares-Gómez M, Abbes H, Villapalos-García G, de Miguel A, González-Iglesias E, Rodríguez-Lopez A, Mejía-Abril G, Martín-Vilchez S, Luquero-Bueno S, Román M, Abad-Santos F. Soria-Chacartegui P, et al. Among authors: luquero bueno s. Int J Mol Sci. 2023 Oct 17;24(20):15265. doi: 10.3390/ijms242015265. Int J Mol Sci. 2023. PMID: 37894954 Free PMC article.
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers.
Hernández-Jiménez M, Martín-Vílchez S, Ochoa D, Mejía-Abril G, Román M, Camargo-Mamani P, Luquero-Bueno S, Jilma B, Moro MA, Fernández G, Piñeiro D, Ribó M, González VM, Lizasoain I, Abad-Santos F. Hernández-Jiménez M, et al. Among authors: luquero bueno s. Mol Ther Nucleic Acids. 2022 Mar 9;28:124-135. doi: 10.1016/j.omtn.2022.03.005. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35402075 Free PMC article.
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline.
Zubiaur P, Matas M, Martín-Vílchez S, Soria-Chacartegui P, Villapalos-García G, Figueiredo-Tor L, Calleja S, Navares-Gómez M, de Miguel A, Novalbos J, Mejía-Abril G, Luquero-Bueno S, Román M, Ochoa D, Abad-Santos F. Zubiaur P, et al. Among authors: luquero bueno s. Pharmaceutics. 2022 Sep 21;14(10):2001. doi: 10.3390/pharmaceutics14102001. Pharmaceutics. 2022. PMID: 36297437 Free PMC article.
11 results